Airomir inhalers are an effective treatment for asthma, providing short -term relief from the associated symptoms. Airomir belongs to the group of inhalers known as 'relievers'. Reliever inhalers can also be used to help prevent asthma symptoms from occurring after exercise, and to relieve breathing problems associated with certain respiratory conditions, such as COPD. Airomir inhalers contain the active ingredient Salbutamol Sulphate. After inhalation, salbutamol will begin to ease breathing within five minutes, with the effects continuing to work for up to six hours. Airomir inhalers are manufactured by Teva UK and are classified as a prescription-only-medicine (POM).
There are two variations of the Airomir inhaler available. The first is the Airomir aerosol inhaler. Administering this device involves pressing down on a metal canister, which triggers the release of 100 micrograms of the active ingredient, salbutamol. This action requires timing the inhalation to coincide with the manual compression of the canister. Poor timing with this action can result in the user not getting the full dose. For this reason, it is important to have regular check-ups with your GP or asthma nurse to ensure your inhaler technique is effective.
The second variation is the Airomir Autohaler. The device, once primed, will automatically release a measured dose when the user inhales from the mouthpiece. For many, this is the preferred option as it doesn't require coordinating activation with inhalation.
Repeat supplies of Airomir Inhaler and Autohaler are available to buy from The Independent Pharmacy's Online Doctor service, following a free consultation, to help control asthma in those who have been diagnosed with the condition by their GP.
Generally, asthma inhalers can be categorised into two types. 'Preventer' inhalers , which usually contain a corticosteroid, are taken regularly to help reduce the inflammation of the airways. This action will help reduce and control the chances of experiencing asthma symptoms or an asthma attack. Salbutamol-based inhalers, such as Airomir, are known as 'Reliever inhalers'. These are used on a 'when required' basis, to help relieve asthma symptoms. Airomir can also be used pre-emptively before you exercise or encounter known asthma-triggering allergens.
Salbutamol belongs to a group of medicines called short-acting beta 2 agonists. This group of medicines acts on the beta 2 receptors found in the lungs. When these receptors are stimulated, it causes the muscles in the airways to relax, which allows the airways to expand. This action helps to relieve asthma symptoms, such as coughing, wheezing, shortness of breath, and tightness in the chest.
Asthma affects over five million people in The UK. The condition is the result of inflammation in the bronchial airways (the tubes that connect the windpipe to the lungs). The associated swelling causes the airways to contract, which will obstruct the flow of air through the passages. The inflammation of the bronchi will also result in an increased production of phlegm. This further serves to obstruct the airways. The resulting symptoms include; coughing, wheezing, tight chest and a shortness of breath.
Although asthma is a common condition throughout the world, people's experiences with the triggers and symptoms can vary. Depending on the sufferer, an asthma attack can be brought on by; allergens, airborne pollutants, infections, cold air, exercise, or stress. Why certain people are more sensitive to these irritants isn't fully understood. However, genetics seems to play a role, as having a family history of the condition increases the likelihood of having asthma.
Why choose The Independent Pharmacy?
- Fast delivery - order before 4pm and receive your treatment as quickly as the next day
- Free online consultation service with one of our registered GMC doctors
- Discreet packaging & confidential service - we don't include any branding or pharmacy logo on our packaging meaning you can get your treatment delivered anywhere
- UK based and GMC UK registered Doctors
- Only proven prescription medication available
- Approved by the National Pharmacy Association and Care Quality Commission.
The recommended dosage for adults is one or two inhalations from the Airomir inhaler, as required. This will help prevent symptoms of asthma if taken 10 to 15 minutes before exercise or exposure to allergens.
For the standard Airomir inhaler, inhale as you press down on the metal canister. Check with your doctor frequently to ensure that you are using the correct technique. Once primed, the Airomir Autohaler automatically releases the salbutamol when you inhale from the mouthpiece.
If your symptoms require you to use your Airomir inhaler more than eight times within a day, inform your GP – there may be a better treatment for your condition.
Not everyone will experience side effects when they use Airomir inhalers, however, if you do they can include:
Dizziness, headache, feeling tense, mild trembling or shaking.
If you are concerned about these effects, or if the product affects you in any other way, stop using it and talk to your doctor or pharmacist.
Reading the following warnings carefully will help to ensure you are selecting an appropriate product.
Before using Airomir inhalers, inform your doctor if any of the following conditions apply to you:
- Thyroid problems
- High blood pressure
- A history of heart disease
- Irregular heart rhythm
- Acute severe asthma
You should also inform your doctor if you take or intend to take any of these medicines:
- Xanthines (such as aminophylline or theophylline)
- Long-term laxatives
- Medication for heart disease (such as digoxin)
- Monoamine oxidase inhibitor (MOAI) antidepressants
- Tricyclic antidepressants.
Please read all packaging and the Product Information Leaflet before taking any new medicine and inform your doctor of medicines you are taking or intend to take.
Airomir Inhalers also contain the following ingredients to make up the complete product:
Oleic acid, ethanol, propellant HFA-134a.
Airomir does not contain chlorofluorocarbon propellants; this is replaced by propellant HFA-134a.